NCT02445976 2019-02-01
Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.
Innocrin Pharmaceutical
Phase 2 Completed
Innocrin Pharmaceutical
Innocrin Pharmaceutical
Innocrin Pharmaceutical